NCBiotech’s Flash Grant program aims to identify and energize the most creative ideas that exhibit early indications of commercial potential. Like a flash of inspiration, Flash Grants infuse funding at a critical early point when a small, targeted influx of funds can be crucial to shaping innovative research ideas into high potential life sciences technologies, particularly in emerging and converging life sciences sectors. 

Flash Grants are used to demonstrate the disruptive potential of a technology or to move a technology into the translational research phase of development.

For fiscal year 2021, there will be three submission cycles for the Flash Grant program. Cycle-specific guidelines will be posted prior to each deadline.

Cycle 1:  Deadline Wednesday, August 12, 2020 (noon)  

• Novel antibiotics and therapeutics targeting antibiotic-resistant bacteria
• Global Coronavirus disease (COVID-19) outbreak - COVID-19-specific therapies, vaccine development, diagnosis, and epidemiology

Cycle 2:  Deadline Wednesday, November 11, 2020 (noon) 

• Microbiome/microbiota in health and disease states
• SARS-CoV-2 Gastrointestinal effects
• SARS-CoV-2 detection via wastewater

Cycle 3:  Deadline Wednesday, March 10, 2021 (noon)

• Open round; all topics with some restrictions

Applicant organizations must be North Carolina universities or non-profit research institutions. Companies are not eligible to apply for Flash Grant awards.